Drugs / Dextran sulfate
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT00001009 | ? → Apr 1990 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 1 | NCT00000690 | ? → Oct 1989 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00000684 | ? → Apr 1991 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dextran sulfate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000684 ↗ |
| Known as | UA001 | “A Phase I/II Dose Ranging Trial of Oral Dextran Sulfate (UA001) in HIV Infected Individuals and in Patients With Acquired Immunodeficiency Syndrome (AIDS) or AIDS Related Complex (ARC)” NCT00001009 ↗ |
| Action | Inhibit | “Dextran sulfate appears to inhibit HIV in experiments in the test tube” NCT00000684 ↗ |
| Route | Intravenous | “receive a continuous infusion of dextran sulfate through an intravenous line for 14 days” NCT00000684 ↗ |